MSK Disorder is a major cost driver for ACOs
July 07,2021
About 874 billion dollars have been consumed by MSK disorders annually in the United States which accounts for 5.7 percent of the United States annual GDP. It has been reported that despite allocating such an amount for musculoskeletal pains, the outcomes are not improved significantly. The long-term pain and physical limitation due to MSK issues affect the quality of life and work productivity from people across the country.
A study reports that about 25 percent of the US population suffers from chronic pain. With the increasing burden of MSK disorders, many studies are conducted to analyze the causes and to find an optimal treatment to reduce pain.
Accountable Care Organizations are working to provide improved quality of care that ensure enhanced outcomes. . With digital healthcare platforms like BlueJay, ACOs can achieve their goals most effectively in MSK treatments and other chronic disease management areas.
BlueJay is a simple tool that enables providers to send evidence-based Home Exercise Programs to their patients.
Through BlueJay our clients can achieve:
• Managed home exercises for patients
• Improved outcomes
• Better patient satisfaction
• Reduced overall costs
We hope to help ACO’s to manage musculoskeletal disorders cost effectively.